Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
47 studies found for:    Open Studies | "Sjogren's Syndrome"
Show Display Options
Rank Status Study
1 Recruiting Implantology and Sjögren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Device: Biohorizons Laser-lok bonelevel dental implants
2 Recruiting Study of Iguratimod in Sjögren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Iguratimod
3 Recruiting Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CFZ533 active - Cohort 1;   Drug: CFZ533 placebo- Cohort 1;   Drug: CFZ533 active - Cohort 2;   Drug: CFZ533 placebo - Cohort 2
4 Recruiting Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: SS-1;   Drug: Placebo
5 Not yet recruiting Acupuncture for Primary Sjögren Syndrome
Condition: Sjogren's Syndrome
Interventions: Device: acupuncture group;   Device: Sham Acupuncture group
6 Recruiting Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Intervention: Drug: Abatacept SC
7 Recruiting Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: SS-1;   Drug: Placebo
8 Recruiting Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Belimumab;   Drug: Rituximab;   Drug: Placebo belimumab;   Drug: Placebo rituximab
9 Not yet recruiting Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Condition: Primary Sjögren's Syndrome
Intervention: Other: Blood samples
10 Recruiting A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
Condition: Sjögren's Syndrome
Interventions: Drug: LY3090106;   Drug: Placebo
11 Recruiting A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Matching Placebo;   Drug: RO5459072
12 Recruiting Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Filgotinib;   Drug: GS-9876;   Drug: Tirabrutinib;   Drug: Filgotinib placebo;   Drug: GS-9876 placebo;   Drug: Tirabrutinib placebo
13 Recruiting Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: BMS-931699;   Drug: BMS-986142;   Drug: Placebo
14 Not yet recruiting Inflammatory Myopathies in Primary Sjögren's Syndrome
Condition: Primary Sjögren Syndrome
Intervention:
15 Not yet recruiting Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
Condition: Primary Sjogren's Syndrome
Interventions: Biological: VAY736;   Other: Placebo
16 Recruiting A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: hrIL-2 active;   Drug: hrIL-2 placebo
17 Recruiting A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Biological: AMG 557/MEDI5872;   Other: Placebo
18 Recruiting Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CDZ173;   Drug: Placebo
19 Recruiting Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?
Conditions: Sjögren's Syndrome;   Meibomian Gland Dysfunction
Interventions: Drug: Tears Naturale Forte;   Drug: liposic
20 Recruiting UCB Proof of Concept Study in Patients With Primary Sjogren's Syndrome
Condition: Primary Sjogren's Syndrome
Interventions: Drug: UCB5857;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.